title: By any other name: ambiguity in marketing proprietary anti-infective agents.
abstract: In 55 instances, a single proprietary (trade) name has been used to market > or = 2 distinct generic anti-infective agents. In some cases, one trade name represents 2 different drugs in the same country--or even marketed by the same manufacturer. Some unrelated drugs and poisonous substances are also manufactured under trade names assigned to anti-infectives. The use of proprietary names in the prescribing of anti-infective drugs could result in considerable confusion or harm to patients.
authors.affiliation: Division of Geographic Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel. mberger@post.tau.ac.il
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Berger
mesh_terms: D000890:Anti-Infective Agents; D004345:Drug Industry; D016568:Drugs, Generic; D006801:Humans; D040541:Marketing / Q000706:statistics & numerical data; D004364:Pharmaceutical Preparations; D009626:Terminology as Topic
chemical_list: D000890:Anti-Infective Agents; D016568:Drugs, Generic; D004364:Pharmaceutical Preparations